A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by the presence of tissue destruction and effacement of the architecture of the involved tissues. It includes the following variants: polymorphic, monomorphic, and classical Hodgkin lymphoma post-transplant lymphoproliferative disorders. [from
NCI]